drug companies

Top Executives Leaving JPMorgan, Avon

Another top executive is leaving JPMorgan Chase: one of two COOs will become the ninth exec to leave in the past year and a half. And Avon chairman Fred Hassan has resigned.

Is Your Doctor on Big Pharma's Payroll?

Drug companies spend hundreds of millions of dollars a year to influence doctors' prescribing habits -- money that often goes directly into physicians' pockets for "consulting fees" and "educational presentations." Wondering if your doc one of them? The nonprofit journalists at ProPublica can tell you.

Big Pharma Ads Flaunt FDA Rules

Officially, it's the FDA's job to ensure that pharmaceutical ads adhere to guidelines. But the agency's annual compliance budget is $9 million, while drug companies spend $58 billion a year on marketing. So it comes as no surprise that only 18% of ads are in compliance with the rules. But it's still disturbing: This is your health.

Swine Flu Response Wasn't Influenced by Vaccine Makers

During the H1N1 swine flu pandemic, much criticism was leveled at World Health Organization officials, accusing their response of being too heavily influenced by the pharmaceutical industry. But according to a panel of independent experts, that wasn't the case.

Why Samsung Electronics Should Say No to Drugs

Samsung Electronics is known for its smartphones, TVs and memory chips. Now it wants to tackle biopharmaceuticals, on Friday announcing a new joint venture to produce drugs to treat cancer and arthritis.

More Proof That Whistleblowing on Medicaid Fraud Works

Whistleblowing firm Ven-A-Care has recovered $2 billion for taxpayers by suing drug companies that overcharge the government and create windfalls for participating pharmacies. It also has made $380 million for itself. What's the problem with that?

The New-Drug Pipeline: U.S. Biotechs Lead the Way

The U.S. leads the world in creating new drugs, and big pharmaceutical companies companies play an important role in the process. But according to a new study, a unique system of collaboration between universities and small biotech firms is the key to the system.

Sanofi Is in No Rush to Reach Deal With Genzyme

Sanofi-Aventis CEO Chris Viehbacher said Wednesday that he believes his French pharmaceutical company will eventually buy U.S. biotech company Genzyme at a reasonable price. However, he expects it will take some time to agree on a deal, and he won't rush into anything.

Four Pharmacy Stocks Getting a Boost From Reform

Health care reform will benefit millions of people, and many companies stand to gain as well. In particular, pharmacies and pharmacy benefit managers will garner new business as they help cover all of these newly insured Americans. And their profits should rise accordingly.

Companies and Investors Scramble to Measure the Effects of Health Care Reform

The House of Representatives finally passed a health care reform bill. The fight over the bill has gone on for months and during that period it had been changed dozens of times compared to the original White House proposal. The bill barely passed with at 219 to 212 margin. What will the effect be on companies and investors?

Will free Viagra boost the economy?

When I first heard about Pfizer Inc.'s (PFE) plans to give unemployed people free access to its most widely prescribed medicines, including the...